VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
33 hedge funds and large institutions have $11.6M invested in Vincerx Pharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
Holders
33
Holders Change
-3
Holders Change %
-8.33%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$208K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$233K |
3 |
3
Morgan Stanley
New York
|
$41.9K |
4 |
4
Wells Fargo
San Francisco,
California
|
$157 |